Sirona Biochem Corp. | |
Stock Exchange | Other OTC |
EPS |
$0.01 |
Market Cap |
$73.45 M |
Shares Outstanding |
172.23 M |
Public Float |
- |
Sirona Biochem Corp. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
EUR0.01 |
Market Cap |
EUR70.16 M |
Shares Outstanding |
172.23 M |
Public Float |
- |
Sirona Biochem Corp. | |
Stock Exchange | Toronto Ventures Stock Exchange |
EPS |
CAD0.01 |
Market Cap |
CAD96.29 M |
Shares Outstanding |
207.07 M |
Public Float |
151.91 M |
Address |
595 Burrard Street Vancouver British Columbia V7X 1L3 Canada |
Employees | - |
Website | http://www.sironabiochem.com |
Updated | 07/08/2019 |
Sirona Biochem Corp. engages in the development of diabetes therapeutics, skin depigmenting, and anti-aging agents for cosmetic use, biological ingredients, and cancer vaccine antigens. It also involves in utilizing a proprietary chemistry technique to improve pharmaceutical properties of carbohydrate-based molecules. The company was founded by Howard Jarman Verrico on October 19, 2006 and is headquartered in Vancouver, Canada. |